NF449 (sodium salt)

Confirm delete?

NF449 (sodium salt)

Zoom

Cat No: 13324

Biochemicals - Ion Channel Modulation

NF449 is an analog of suramin that selectively inhibits P2X1 purinergic receptors (pIC50 = 6.3) with a potency 19-fold greater than at P2X3, P2Y1, P2Y2, or P2Y11.{23042,23041} Through selective inhibition of the P2X1 receptor, 10 mg/kg NF449 has been ...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Synonyms:

4,4',4'',4'''-[carbonylbis[imino-5,1,3-benzenetriylbis(carbonylimino)]]tetrakis-1,3-benzenedisulfonic acid, octasodium salt

Correlated keywords:

389142-38-5 suramin inhibitors P2X1 platelets aggregations thromboembolism G-proteins antagonists inhibits inhibitions G proteins Gproteins NF-449 NFs 449 analogs 11126 purinergic potent potency decreases intravascular platelets aggregation mouse mice models systemic antagonism Gsa Gs? Gsalpha Gs.alpha. subunits adenylyl cyclase activity GPCRs P2Y1 P2Y2 P2Y11 selective supresses supression associations rates binding binds stimulation stimulates blocks coupling active

Product Overview:
NF449 is an analog of suramin that selectively inhibits P2X1 purinergic receptors (pIC50 = 6.3) with a potency 19-fold greater than at P2X3, P2Y1, P2Y2, or P2Y11.{23042,23041} Through selective inhibition of the P2X1 receptor, 10 mg/kg NF449 has been used to decrease intravascular platelet aggregation in a mouse model of systemic thromboembolism.{23040} NF449 has also demonstrated selective antagonism of the Gsα-subunit G protein, which suppresses the association rate of GTPγS binding to Gsα-s, inhibits the stimulation of adenylyl cyclase activity, and blocks G protein coupling to certain GPCRs.{23039}

Size	1 mg
Shipping	dry ice
CAS Number	627034-85-9
Molecular Formula	C₄₁H₂₄N₆O₂₉S₈ • 8Na
SMILES	O=C(NC1=CC(C(NC2=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C=C2)=O)=CC(C(NC3=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C=C3)=O)=C1)NC4=CC(C(NC5=CC=C(S([O-])(=O)=O)C=C5S([O-])(=O)=O)=O)=CC(C(NC6=CC=C(S([O-])(=O)=O)C=C6S([O-])(=O)=O)=O)=C4.[Na+].[Na+].[Na+].[Na+].[Na+].[Na
Molecular Weight	1505,1
Formulation	A crystalline solid
Purity	≥95%
Custom Code	2922.19
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.